B Cell Epitope Mapping by High-Density Competition ELISAs.

Methods Mol Biol

Division of Infectious Disease, New York State Department of Health, Wadsworth Center, Albany, NY, USA.

Published: July 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Advances in the discovery and expression of large libraries of monoclonal (MAb) and single-domain (VH) antibodies against protein antigens necessitate a means by which to rapidly bin antibodies before embarking on resource-intensive epitope mapping methods such as cryogenic electron microscopy (EM) and X-ray crystallography. In this chapter we describe the use of competition enzyme-linked immunosorbent assays (ELISAs) for the purpose of epitope binning antibodies from any given species. In its simplest form, a competition ELISA compares the ability of a query MAb (or VH) to bind to an immobilized target antigen in the presence of a competitor MAb (or VH) whose epitope is already known. Detection of the query MAb is achieved through an enzyme-linked, species-specific secondary antibody and developed using a colorimetric substrate. While useful, the indirect competition ELISA has several drawbacks that may limit its applications for large screens, including artifacts associated with immobilization of protein antigens on polystyrene microtiter plates. We discuss alternative competition ELISA strategies involving the capture of soluble antigen without and with biotin tagging. We also describe how competition ELISAs, once optimized, can be employed along with large antibody collections to yield fine resolution epitope maps of protein antigens.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-0716-4591-8_21DOI Listing

Publication Analysis

Top Keywords

protein antigens
12
competition elisa
12
competition elisas
8
describe competition
8
query mab
8
competition
6
cell epitope
4
epitope mapping
4
mapping high-density
4
high-density competition
4

Similar Publications

Amplifying antigen-induced cellular responses with proximity labelling.

Nature

September 2025

Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Key Laboratory of RNA Innovation Science and Engineering, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.

Antigen-induced clustering of cell surface receptors, including T cell receptors and Fc receptors, represents a widespread mechanism in cell signalling activation. However, most naturally occurring antigens, such as tumour-associated antigens, stimulate limited receptor clustering and on-target responses owing to insufficient density. Here we repurpose proximity labelling, a method used to biotinylate and identify spatially proximal proteins, to amplify designed probes as synthetic antigen clusters on the cell surface.

View Article and Find Full Text PDF

Ferroptosis is involved in the progression of sepsis-induced acute lung injury (ALI). Kaempferol is a flavonoid compound that can protect against ALI. 5-Methylcytosine (m5C) is involved in the pathogenesis of sepsis.

View Article and Find Full Text PDF

Background: Tumor heterogeneity and antigen escape are mechanisms of resistance to chimeric antigen receptor (CAR)-T cell therapy, especially in solid tumors. Targeting multiple antigens with a unique CAR construct could be a strategy for a better tumor control than monospecific CAR-T cells on heterogeneous models. To overcome tumor heterogeneity, we targeted mesothelin (meso) and Mucin 16 (MUC16), two antigens commonly expressed in solid tumors, using a tandem CAR design.

View Article and Find Full Text PDF

Comparative efficacy and safety of PSCA CAR-engineered Vδ1 γδ T cells for immunotherapy of pancreatic cancer.

J Immunother Cancer

September 2025

Division of Hematology & Oncology, Department of Medicine, School of Medicine, University of California, Irvine, California, USA

Background: γδ T cells possess unique immunological features including tissue tropism, major histocompatibility complex-independent antigen recognition, and hybrid T/natural killer cell properties that make them promising candidates for cancer immunotherapy. However, the therapeutic potential of Vδ1 γδ T cells, particularly when engineered with chimeric antigen receptors (CARs), remains underexplored in solid tumors such as pancreatic cancer (PC), largely due to their low abundance in peripheral blood and challenges in ex vivo expansion. This study aims to directly compare the preclinical safety and efficacy among CAR-engineered Vδ1 γδ T cells, Vδ2 γδ T cells, and conventional αβ T cells.

View Article and Find Full Text PDF

T-cell receptors (TCRs) recognize antigens derived from fragments of somatically expressed proteins that are degraded by the proteasome and presented by specific human leukocyte antigen (HLA) molecules. Recent therapeutic advances using the TCR as a tumor-targeting moiety have focused attention on loss of heterozygosity (LOH) as a potential resistance mechanism. Allele-specific LOH, rather than allele-agnostic, is particularly pertinent, but rarely evaluated.

View Article and Find Full Text PDF